N. Brunetti-Pierri Et Al. , "Safety and Efficacy of Liver-Directed Gene Therapy in Patients with Mucopolysaccharidosis Type VI," MOLECULAR THERAPY , vol.29, no.4, pp.114, 2021
Brunetti-Pierri, N. Et Al. 2021. Safety and Efficacy of Liver-Directed Gene Therapy in Patients with Mucopolysaccharidosis Type VI. MOLECULAR THERAPY , vol.29, no.4 , 114.
Brunetti-Pierri, N., Ferla, R., Ginocchio, V. M., Rossi, A., Fecarotta, S., Romano, R., ... Parenti, G.(2021). Safety and Efficacy of Liver-Directed Gene Therapy in Patients with Mucopolysaccharidosis Type VI. MOLECULAR THERAPY , vol.29, no.4, 114.
Brunetti-Pierri, Nicola Et Al. "Safety and Efficacy of Liver-Directed Gene Therapy in Patients with Mucopolysaccharidosis Type VI," MOLECULAR THERAPY , vol.29, no.4, 114, 2021
Brunetti-Pierri, Nicola Et Al. "Safety and Efficacy of Liver-Directed Gene Therapy in Patients with Mucopolysaccharidosis Type VI." MOLECULAR THERAPY , vol.29, no.4, pp.114, 2021
Brunetti-Pierri, N. Et Al. (2021) . "Safety and Efficacy of Liver-Directed Gene Therapy in Patients with Mucopolysaccharidosis Type VI." MOLECULAR THERAPY , vol.29, no.4, p.114.
@article{article, author={Nicola Brunetti-Pierri Et Al. }, title={Safety and Efficacy of Liver-Directed Gene Therapy in Patients with Mucopolysaccharidosis Type VI}, journal={MOLECULAR THERAPY}, year=2021, pages={114} }